# FDA recall D-0531-2023

> **Pine Pharmaceuticals, LLC** · Class III · drug recall initiated 2023-03-27.

## Product

Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging).  Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150,  Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0531-2023
- **Recalling firm:** Pine Pharmaceuticals, LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-03-27
- **Report date:** 2023-04-19
- **Termination date:** 2023-06-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Tonawanda, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0531-2023

## Citation

> AI Analytics. FDA recall D-0531-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0531-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*